a doc myself, u know they're around best when it comes to heart care, but u're gettin better care for lesser.. for them to start making real profit, will've to wait till cases come along in pretty good numbers.. so may be it'll pay >2yrs.. many a falls till then so better to wait.. wad do u feel? i'm just a novice in this
AVOID THIS IPO TAKE A LESSON FROM FORTIS. ONLY THOSE WHO CAN WAIT FOR OVER THREE YEARS MAY CONSIDER KEEPING IN VIEW THE INCREASING TREND OF MEDICAL TOURISM.
this is unfairly high - priced ipo. healthcare sector cannot give immediate returns...so it is ve..r...y.....v..e..r......y long term. don't go for speculation. go by the fundamentals of the company and you can understand that fair price is around rs.150.
rather invest in guj.ambuja exports at this price..you will have much higher gains....
I think it is a best IPO for the investment/ Avoid this IPO, what happened to Fortis Health care ( Ranbaxy group)ipo was at 108 & was 64 yday.......never gave chance to earn
Hospital Concept good but u can buy after 2 years to get real benifit...will get cheaper after listing This is one of the best IPO in the Hospital Healthcare category. You will soon see Apollo Hospitals coming with an IPO. Wockhardt is an associate of Harvard Medical Services(USA). Also the future has tremendous prospects for healthcare with the GoI laying an increased emphasis on this segment through greater budget allocation. So whoever says avoid, is a big fool.
Health sector is for very very long term, may be 5-7 years. Not good for immediate gain. Even Fortis Healthcare is hanging below allotment price. This issue is costly. Its fair price is around Rs. 200/-.
Carol Info has stack of almost 10% in this company. The carol info is available at just rs 75 at BSE. Investor should buy Carol to double their money around the listing of this Issue. Investor can check RHP of this IPO for confirmation of stack of Carol Info.
COMPANIES WITH IPO'S IN THE NEXT FEW DAYS ARE NOT REVIEWING THEIR PRICES. CLEARLY IPO'S LIKE ON-MOBILE & EMAAR MGF ARE LOT EXPENSIVE THEN THEY SHOULD BE IN ALL FAIRNESS TO THE SUBSCRIBERS. BUT STILL THEY WOULD NOT LESSEN THE PRICES.
LAST FEW ISSUES WERE EXENSIVE AND DID NOT DO WELL. NOW J KUMAR AND CORDS CABLE IS NOT GETTING SUBSCRIBED. MARKETS CORRECTED SO MUCH LAST 2 DAYS. BUT STILL....
LOOKING AT THE IPO RESPONSE IN THE PAST FEW MONTHS AND GROWING CRAZE, COMPANIES ARE NOW PRICING THEIR ISSUES LOT HIGHER. LEAVING MUCH LESSER FOR INVESTORS.
This is one of the best IPO in the Hospital Healthcare category. You will soon see Apollo Hospitals coming with an IPO. Wockhardt is an associate of Harvard Medical Services(USA). Also the future has tremendous prospects for healthcare with the GoI laying an increased emphasis on this segment through greater budget allocation. So whoever says avoid, is a big fool.
being a professional, i suggest do not go for this ipo because it's an expensive ipo. INVESTORS,PLZ DO NOT IGNORE FUNDAMENTALS, STAY AWAY FROM SPECULATION